You are on page 1of 3

The Value-Based Hospital and Translational Medicine

Register
Login

CEO Agenda
Industries
Business Topics
Viewpoints
Article image
The Value-Based Hospital and Translational Medicine
September 09, 2014 by Elisabeth Hansson, Brett Spencer, James Kent, Jennifer Cla
wson, Heino Meerkatt, and Stefan Larsson
Categories: Health Care, Transformation & Turnaround
Add To Interests
SAVE CONTENT
PRINT
PDF
Increase font size
text
Decrease font size
Related Articles
Health Care October 2014
The Value-Based Hospital: A Transformation Agenda
Health Care September 2014
Texas Health Resources: Value-Based Bundles
Health Care September 2014
Munich City Hospital: Value-Based Consolidation
Health Care September 2014
What Health Care Value Means to Me: An Interview with Terveystalo CEO Yrj Nrhi
nen
Health Care September 2014
The Value-Based Hospital
Health Care September 2014
The Growing Standardization of Health Outcomes Metrics
In This Article
Translational medicine from bench to bedside has become a major goal of biomedical
research.
The traditional model of health care delivery, however, is not well suited t
o the demands of clinical research.
When the measurement of health outcomes is part of care delivery, it becomes
possible to fully align research and clinical practice.

Value-Based Health Care seriesFor academic medical centers, the increased focus
on measuring and understanding patient outcomes comes with an added benefit: the
opportunity to achieve better connections between research and health care deli
very. Over the past 15 years, so-called translational medicine from bench to bedsid
e has been a major goal of biomedical research. And yet, the traditional model of h
ealth care delivery with its functional organization of specialist departments, it
s increasing focus on productivity rather than quality of care, and its weak dat
a management is not well suited to the demands of clinical research, even in a uni
versity hospital setting. This disconnect has been a major reason for the declin
ing number of clinical trials in many countries.
Most medical research focuses on diseases and patient groups, on measuring end r
esults and outcomes, and on strict data management and analysis. The requirement
to collect data separately outside the everyday care-delivery process has not only
made research expensive but also created a cultural barrier in which research is
often considered a special interest with a limited direct linkage to the improv
ement of clinical practice and, ultimately, health outcomes.
When the measurement of real-world health outcomes is part of care delivery, how
ever, it becomes possible to fully align research and clinical practice. A good
example of this principle is the recent use of large, low-cost, registry-based,
randomized clinical trials in which outcomes data collected routinely by disease
-specific quality registries is used to assess the effectiveness of existing cli
nical practices and treatments.
For instance, a team of Swedish, Danish, and Icelandic researchers recently cond
ucted a multicenter, prospective, randomized, controlled, open-label clinical tri
al to test the effectiveness of coronary-artery thrombosis aspiration, a techniqu
e that is increasingly used along with percutaneous coronary intervention (PCI)
for patients suffering from ST-segment-elevation myocardial infarction (STEMI),
a type of heart attack. The trial enrolled 7,244 STEMI patients from the compreh
ensive Swedish Coronary Angiography and Angioplasty Registry. The patients were
randomly assigned to receive either manual thrombus aspiration followed by PCI o
r PCI alone. The study found that routine thrombus aspiration before PCI did not
significantly reduce mortality and, therefore, did not contribute to health car
e value.
Add To Interests
SAVE CONTENT
PRINT
PDF
Back to top
CEO Agenda
Big Data & Beyond
Global Advantage
Leadership & Talent
Six Simple Rules
Strategy Needs a Strategy
Sustainability
Winning in the Digital Economy
Industries
Automotive
Consumer & Retail
Energy & Environment
Financial Services
Hardware, Software, & Telecommunications
Health Care

Industrial Products & Processes


Media & Entertainment
Private Equity
Public Sector
Social Sector
Transportation, Travel, & Tourism
Business Topics
Change Management
Corporate Development & Finance
Innovation & Growth
Marketing & Sales
Operations
People & Organization
Postmerger Integration
Strategy
Technology & Digital
Transformation
Viewpoints
BCG Fellows
Classics
Now Is the Time
TED@BCG
Home
Help
Contact Us
Site Map
Terms of Use
Privacy Policy
BCG.com
Rss Feeds
Feedback
Mobile
TABLET APP
Copyright 2015
The Boston Consulting Group
All rights reserved
Boston Consulting Group

You might also like